Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Akynzeo plus dexamethasone for antiemetic prophylaxis during weekly cisplatin chemoradiotherapy in cervical cancer
2017-004031-37Phase 2Completed
- Sponsor
- University Hospital Odense
- Start
- Oct 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of palonosetron and dexamethasone in Nausea and Vomiting, sponsored by University Hospital Odense. Primary endpoint: Safety of antiemetic regimen during 5 weeks of chemoradiotherapy. Started Oct 2017; status: completed.
02
Drugs
palonosetrondexamethasone
03
Conditions
Nausea and Vomiting
Beyond the preview
Go deeper on 2017-004031-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004031-37.